Sina Rashedi Profile
Sina Rashedi

@SinaRsh

Followers
429
Following
1K
Statuses
139

MD-MPH; Postdoctoral Research Fellow @BrighamWomens @harvardmed; @bwh_postdocs; #cardiology #thrombosis

Boston, MA, USA
Joined March 2014
Don't wanna be here? Send us removal request.
@SinaRsh
Sina Rashedi
3 months
Thrilled to present my research on the accuracy of Nation Language Processing Tools for Pulmonary Embolism Identification at the #AHA2024. My deepest thanks should go to Dr. @bbikdeli and Dr. Piazza for all their support. @AHAScience @BrighamResearch @BrighamFellows @harvardmed
@bbikdeli
Behnood Bikdeli
3 months
Last but not least from #PE-EHR+ in @AHAMeetings #AHA24 @SinaRsh presenting results of the #NLP component of the project! Bottom line: these tools are promising but external validation shows we need modifications to ✅ sensitivity and PPV.
Tweet media one
Tweet media two
5
8
53
@SinaRsh
Sina Rashedi
2 hours
RT @UjuetaFrancisco: Understanding the pain experience in patients with PAD @AHAScience @BrighamResearch
0
2
0
@SinaRsh
Sina Rashedi
13 hours
RT @UjuetaFrancisco: Understanding the pain experience in patients with peripheral arterial disease @AHAScience @KimGSmolderen @CarlosMenaY
0
3
0
@SinaRsh
Sina Rashedi
4 days
RT @rkwadhera: In @JAMACardio, we compare cardiovascular hospitalization rates in the US 🇺🇸 to another high-income country w/ a universal h…
0
23
0
@SinaRsh
Sina Rashedi
5 days
RT @AryaAminorroaya: Can we leverage #EHR and ARISE, an #ML tool, to find 👥with ⬆️ Lp(a)? Our piece @Circ_Gen addresses this🤔, building o…
0
9
0
@SinaRsh
Sina Rashedi
18 days
@ACCinTouch Very interesting study! ECG for HF risk! Congrats @AryaAminorroaya !
1
1
3
@SinaRsh
Sina Rashedi
18 days
RT @ACCinTouch: A novel #AI model applied to a 12-lead #ECG image was able to identify individuals at elevated risk of HF across multinatio…
0
9
0
@SinaRsh
Sina Rashedi
18 days
RT @NEJM: New in the January 23, 2025, issue of NEJM: Perioperative Chemotherapy in Esophageal Cancer (ESOPEC trial)
0
11
0
@SinaRsh
Sina Rashedi
19 days
RT @DFCapodanno: We authored the editorial “Science Behind the Study” for @NEJM, focusing on the AZALEA-TIMI 71 trial, a phase 2b study of…
0
17
0
@SinaRsh
Sina Rashedi
19 days
RT @maciejbanach: Important paper on the trends on #aspirin use in primary and secondary prevention in US. The trend is stable in 2ndary pr…
0
5
0
@SinaRsh
Sina Rashedi
20 days
RT @bbikdeli: Isolated subsegmental #PE is a notorious Dx. 🙏🙏@AHAScience @PVDCouncil @VIVAPhysicians we studied ICD10 codes for SSPE & acc…
0
17
0
@SinaRsh
Sina Rashedi
20 days
0
0
0
@SinaRsh
Sina Rashedi
20 days
@negeen_sh @soniyarabadiamd @NatCamMD @HarborUCLA_WIC @NorthwesternMed @uclaimchiefs @uclaCVfellows @datsunian @kewatson @AleeshaShaikMD @ucla_wic Congrats for this interesting paper! I wondered whether there is any data on pregnancy-associated VTE and subsequent CV outcomes.
1
0
1
@SinaRsh
Sina Rashedi
20 days
0
0
0
@SinaRsh
Sina Rashedi
22 days
@sina_kazemian @m_keykhaei @aknabdMD Thank you so much!
0
0
0
@SinaRsh
Sina Rashedi
23 days
RT @drjohnm: When to stop antiplatelet therapy when patients have AF and take oral anticoagulation is a tough question New meta-analysis o…
0
56
0
@SinaRsh
Sina Rashedi
23 days
@m__babaei @bbikdeli @JACCJournals @BrighamResearch Thank you so much Mohammadreza!
0
0
1
@SinaRsh
Sina Rashedi
24 days
@aknabdMD @m_keykhaei Thank you so much Ashkan!
0
0
2